Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLB1 | P16278 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL232598 | 1.00 | GLB1 (0.33) | GLB1 | |
| Bromide SCHEMBL28188319 | 1.00 | GLB1 (0.33) | GLB1 | |
| Bromide SCHEMBL27863909 | 0.98 | GLB1 (0.32) | GLB1 | |
| Bromide SCHEMBL31276195 | 0.98 | GLB1 (0.32) | GLB1 | |
| Bromide SCHEMBL28282343 | 0.98 | GLB1 (0.32) | GLB1 | |
| Bromide SCHEMBL28161984 | 0.98 | GLB1 (0.32) | GLB1 | |
| Bromide SCHEMBL28622489 | 0.98 | GLB1 (0.32) | GLB1 | |
| SCHEMBL34970 | 0.98 | GLB1 (0.34) | GLB1 | |
| Bromide SCHEMBL28586346 | 0.96 | GLB1 (0.31) | GLB1 | |
| Water SCHEMBL23500119 | 0.95 | GLB1 (0.33) | GLB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040333-A | Preparation method of 5, 6-dihydroxyindoline | 北京成宇化工有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119039160-A | Synthetic method for preparing 3-bromo-4-iodoanisole with high selectivity | 江苏阿尔法药业股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| EP-4267591-A2 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-11-01 | — | — | EP | claimed |
| WO-2022136049-A2 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2022-06-30 | — | — | WO | claimed |
| CN-112451665-B | NIR-II diagnosis and treatment integrated silicon-carbon nanoprobe and preparation method thereof | 山西医科大学 | 2022-06-21 | — | — | CN | claimed |
| US-11344858-B2 | Micro-electrolysis reactor for ultra fast, oxidant free, C—C coupling reaction and synthesis of daclatasvir analogs thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH | 2022-05-31 | — | — | US | claimed |
| CN-114334477-A | Intelligent super capacitor and preparation method thereof | 东莞东阳光科研发有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-112451665-A | Novel NIR-II diagnosis and treatment integrated silicon-carbon nanoprobe and preparation method thereof | 山西医科大学 | 2021-03-09 | — | — | CN | claimed |
| US-20200346182-A1 | MICRO-ELECTROLYSIS REACTOR FOR ULTRA FAST, OXIDANT FREE, C-C COUPLING REACTION AND SYNTHESIS OF DACLATASVIR ANALOGS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2020-11-05 | — | — | US | claimed |
| US-10673094-B2 | Rechargeable non-aqueous Mg—Br2 battery | TRUSTEES OF BOSTON COLLEGE (US) | 2020-06-02 | — | — | US | claimed |
| US-20180323466-A1 | RECHARGEABLE NON-AQUEOUS MG-BR2 BATTERY | Boston College Office of Technology Transfer and Licensing (US) | 2018-11-08 | — | — | US | claimed |
| US-20150162213-A1 | FORMULATIONS FOR WET ETCHING NIPT DURING SILICIDE FABRICATION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2015-06-11 | — | — | US | claimed |
| CN-102030706-B | Method for preparing 6-hydroxy-2(1H)-quinolone in ionic liquid by using one-pot method | JIANGSU FOOD SCIENCE COLLEGE | 2012-07-04 | — | — | CN | claimed |
| CN-101531577-B | Method for preparing 3, 4-dihydroxy benzaldehyde in ionic liquid by one-pot method | JIANGSU FOOD SCIENCE COLLEGE | 2012-05-23 | — | — | CN | claimed |
| CN-102351815-A | Synthesis method of 5-bromo-2-furaldehyde | UNIV HEFEI TECHNOLOGY | 2012-02-15 | — | — | CN | claimed |
| CN-102030706-A | Method for preparing 6-hydroxy-2(1H)-quinolone in ionic liquid by using one-pot method | JIANGSU FOOD SCIENCE COLLEGE | 2011-04-27 | — | — | CN | claimed |
| CN-101531577-A | A method for preparing 3, 4-dihydroxy benzaldehyde in ionic liquid with one-pot method | JIANGSU FOOD SCIENCE COLLEGE | 2009-09-16 | — | — | CN | claimed |
| CN-101186336-A | Method for preparing layer thickness homogenized bismuth oxyhalide | UNIV BEIJING BUAA (CN) | 2008-05-28 | — | — | CN | claimed |
| US-12623988-B2 | Scaleable preparation of polyketides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-12 | — | — | US | disclosed |
| CN-101186336-A | Method for preparing layer thickness homogenized bismuth oxyhalide | UNIV BEIJING BUAA (CN) | 2008-05-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344858-B2 | Micro-electrolysis reactor for ultra fast, oxidant free, C—C coupling reaction and synthesis of daclatasvir analogs thereof | CYCS, COASY, CAT | GLB1 4516/4885 |
| US-12623988-B2 | Scaleable preparation of polyketides | SF3B5, RPS5, RPS25 | GLB1 3996/4885 |
| US-20200346182-A1 | MICRO-ELECTROLYSIS REACTOR FOR ULTRA FAST, OXIDANT FREE, C-C COUPLING REACTION AND SYNTHESIS OF DACLATASVIR ANALOGS THEREOF | CYCS, COASY, CAT | GLB1 4485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.